Cargando…

Polypharmacy Management in the Older Adults: A Scoping Review of Available Interventions

Background: Polypharmacy paves the way for non-adherence, adverse drug reactions, negative health outcomes, increased use of healthcare services and rising costs. Since it is most prevalent in the older adults, there is an urgent need for introducing effective strategies to prevent and manage the pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kurczewska-Michalak, M., Lewek, P., Jankowska-Polańska, B., Giardini, A., Granata, N., Maffoni, M., Costa, E., Midão, L., Kardas, P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8661120/ https://www.ncbi.nlm.nih.gov/pubmed/34899294 http://dx.doi.org/10.3389/fphar.2021.734045

Ejemplares similares

Optimizing polypharmacy management in the elderly: a comprehensive European benchmarking survey and the development of an innovative online benchmarking application
por: Kardas, Przemysław, et al.
Publicado: (2023)

Determinants of patient adherence: a review of systematic reviews
por: Kardas, Przemyslaw, et al.
Publicado: (2013)

A cornerstone of healthy aging: do we need to rethink the concept of adherence in the elderly?
por: Giardini, Anna, et al.
Publicado: (2018)

Prevalence and Age Structure of Polypharmacy in Poland: Results of the Analysis of the National Real-World Database of 38 Million Citizens
por: Kardas, Przemysław, et al.
Publicado: (2021)

Prevalence of Chronic Polypharmacy in Community-Dwelling Elderly People in Poland: Analysis of National Real-World Database Helps to Identify High Risk Group
por: Kardas, Przemysław, et al.
Publicado: (2021)

Frailty Status and Polypharmacy Predict All-Cause Mortality in Community Dwelling Older Adults in Europe
por: Midão, Luís, et al.
Publicado: (2021)

Patients’ Preferences and Willingness to Pay for Solid Forms of Oral Medications—Results of the Discrete Choice Experiment in Polish Outpatients
por: Kurczewska-Michalak, Marta, et al.
Publicado: (2020)

Geriatrician-led multidisciplinary team management improving polypharmacy among older inpatients in China
por: Song, Yi, et al.
Publicado: (2023)

Aging and the Prevalence of Polypharmacy and Hyper-Polypharmacy Among Older Adults in South Korea: A National Retrospective Study During 2010–2019
por: Cho, Ho Jin, et al.
Publicado: (2022)

Barriers and facilitators to maintaining a high level of polypharmacy adherence in people living with HIV: A scoping review
por: He, Jiamin, et al.
Publicado: (2023)

Polypharmacy and Nutraceuticals in Veterans: Pros and Cons
por: Sciarra, Tommaso, et al.
Publicado: (2019)

Polypharmacy to Mitigate Acute and Delayed Radiation Syndromes
por: Gasperetti, Tracy, et al.
Publicado: (2021)

Associated adverse health outcomes of polypharmacy and potentially inappropriate medications in community-dwelling older adults with diabetes
por: Lu, Lvliang, et al.
Publicado: (2023)

Reimbursed medication adherence enhancing interventions in 12 european countries: Current state of the art and future challenges
por: Kardas, Przemysław, et al.
Publicado: (2022)

Psychotropic Polypharmacy in Adults 55 Years or Older: A Risk for Impaired Global Cognition, Executive Function, and Mobility
por: Loggia, Gilles, et al.
Publicado: (2020)

Global prevalence of polypharmacy and potentially inappropriate medication in older patients with dementia: a systematic review and meta-analysis
por: Zhao, Mengnan, et al.
Publicado: (2023)

Corrigendum: Polypharmacy to Mitigate Acute and Delayed Radiation Syndromes
por: Gasperetti, Tracy, et al.
Publicado: (2021)

Polypharmacy Cut-Off for Gait and Cognitive Impairments
por: Langeard, Antoine, et al.
Publicado: (2016)

Community-Level Pharmaceutical Interventions to Reduce the Risks of Polypharmacy in the Elderly: Overview of Systematic Reviews and Economic Evaluations
por: Soler, Orenzio, et al.
Publicado: (2019)

Are Anticholinergic Symptoms a Risk Factor for Falls in Older General Practice Patients With Polypharmacy? Study Protocol for the Development and Validation of a Prognostic Model
por: Dinh, Truc Sophia, et al.
Publicado: (2021)

Prevalence of Polypharmacy, Hyperpolypharmacy and Potentially Inappropriate Medication Use in Older Adults in India: A Systematic Review and Meta-Analysis
por: Bhagavathula, Akshaya S., et al.
Publicado: (2021)

Prevalence of polypharmacy and potentially inappropriate medication use in older lung cancer patients: A systematic review and meta-analysis
por: Tian, Fangyuan, et al.
Publicado: (2022)

Regional variations in excessive polypharmacy and potentially inappropriate drug use among older adults in Sweden: Trends from 2006 to 2020
por: Wastesson, Jonas W., et al.
Publicado: (2023)

Association of polypharmacy with fall-related fractures in older Taiwanese people: age- and gender-specific analyses
por: Pan, Hsueh-Hsing, et al.
Publicado: (2014)

A modified Delphi study to determine the level of consensus across the European Union on the structures, processes and desired outcomes of the management of polypharmacy in older people
por: Stewart, Derek, et al.
Publicado: (2017)

Increasing Trends of Polypharmacy and Potentially Inappropriate Medication Use in Older Lung Cancer Patients in China: A Repeated Cross-Sectional Study
por: Tian, Fangyuan, et al.
Publicado: (2022)

Psychiatric and non-psychiatric polypharmacy among older adults with schizophrenia: Trends from a population-based study between 2000 and 2016
por: Lunghi, Carlotta, et al.
Publicado: (2023)

Recommendations for wider adoption of clinical pharmacy in Central and Eastern Europe in order to optimise pharmacotherapy and improve patient outcomes
por: Urbańczyk, Kamila, et al.
Publicado: (2023)

Diabetes Mellitus Versus Hypertension—Does Disease Affect Pharmacological Adherence?
por: Jankowska-Polańska, Beata, et al.
Publicado: (2020)

Older Age, Polypharmacy, and Low Systolic Blood Pressure Are Associated With More Hypotension-Related Adverse Events in Patients With Type 2 Diabetes Treated With Antihypertensives
por: Ambrož, Martina, et al.
Publicado: (2021)

The prevalence of symptoms and its correlation with sex in polish COVID-19 adult patients: Cross-sectional online open survey
por: Lewek, Pawel, et al.
Publicado: (2023)

An Increasing Trend in the Prevalence of Polypharmacy in Sweden: A Nationwide Register-Based Study
por: Zhang, Naiqi, et al.
Publicado: (2020)

A case study of polypharmacy management in nine European countries: Implications for change management and implementation
por: McIntosh, Jennifer, et al.
Publicado: (2018)

Defining pediatric polypharmacy: A scoping review
por: Bakaki, Paul M., et al.
Publicado: (2018)

Resilience in palliative healthcare professionals: a systematic review
por: Zanatta, Francesco, et al.
Publicado: (2019)

Is Excessive Polypharmacy a Transient or Persistent Phenomenon? A Nationwide Cohort Study in Taiwan
por: Wang, Yi-Jen, et al.
Publicado: (2018)

Low Quality of Warfarin Therapy is Associated With Female Gender but Not With Polypharmacy in Patients With Atrial Fibrillation
por: Takamoto, Kojiro, et al.
Publicado: (2021)

Polypharmacy and associated factors: a gender perspective in the elderly Spanish population (2011–2020)
por: Cebrino, Jesús, et al.
Publicado: (2023)

Prescription Rates, Polypharmacy and Prescriber Variability in Swiss General Practice—A Cross-Sectional Database Study
por: Rachamin, Yael, et al.
Publicado: (2022)

Primary Non-Adherence to Antihistamines—Conclusions From E-Prescription Pilot Data in Poland
por: Kardas, Grzegorz, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_676mde4cjlhql06dh0u44c2t53